Charter Research Investment Group buys $2,325,763 stake in Cardinal Health Inc (CAH)

Cardinal Health Inc (CAH) : Charter Research Investment Group scooped up 450 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Nov 14, 2016. The investment management firm now holds a total of 32,146 shares of Cardinal Health Inc which is valued at $2,325,763.Cardinal Health Inc makes up approximately 2.79% of Charter Research Investment Group’s portfolio.

Other Hedge Funds, Including , Annex Advisory Services boosted its stake in CAH in the latest quarter, The investment management firm added 28 additional shares and now holds a total of 8,195 shares of Cardinal Health Inc which is valued at $592,908. Cardinal Health Inc makes up approx 0.16% of Annex Advisory Services’s portfolio.Jaffetilchin Investment Partners reduced its stake in CAH by selling 651 shares or 13.14% in the most recent quarter. The Hedge Fund company now holds 4,303 shares of CAH which is valued at $297,983. Cardinal Health Inc makes up approx 0.10% of Jaffetilchin Investment Partners’s portfolio.Winton Group Ltd boosted its stake in CAH in the latest quarter, The investment management firm added 27,542 additional shares and now holds a total of 675,199 shares of Cardinal Health Inc which is valued at $44,563,134. Cardinal Health Inc makes up approx 0.78% of Winton Group Ltd’s portfolio.Girard Partners Ltd. boosted its stake in CAH in the latest quarter, The investment management firm added 3,651 additional shares and now holds a total of 27,932 shares of Cardinal Health Inc which is valued at $1,820,328. Cardinal Health Inc makes up approx 0.63% of Girard Partners Ltd.’s portfolio.

Cardinal Health Inc closed down -0.87 points or -1.21% at $70.77 with 26,53,027 shares getting traded on Monday. Post opening the session at $71.53, the shares hit an intraday low of $70.6501 and an intraday high of $71.59 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Cardinal Health Inc reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Oct 31, 2016. Analyst had a consensus of $1.20. The company had revenue of $32039.00 million for the quarter, compared to analysts expectations of $31007.13 million. The company’s revenue was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.38 EPS.

Many Wall Street Analysts have commented on Cardinal Health Inc. Shares were Downgraded by Robert W. Baird on Oct 28, 2016 to ” Neutral” and Lowered the Price Target to $ 82 from a previous price target of $92 .Cardinal Health Inc was Downgraded by Goldman to ” Neutral” on Sep 16, 2016.

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Leave a Reply

Cardinal Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cardinal Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.